Stock Gaps Up and Down for Feb-12 Morning

These stocks have gapped above or below the previous day’s close.

Gaps Up

NeuroMetrix Inc. (NURO) < (NURO) had a gap up today of 0.1293 points or 4.37% above its previous close of $2.96. NeuroMetrix Inc. (NURO) < is currently trading at $3.17 + 0.2122 (7.17%).

NeuroMetrix Inc is engaged in product development, manufacturing, regulatory affairs and sales and marketing. It mainly produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes.

vTv Therapeutics Inc. (VTVT) < (VTVT) had a gap up today of 0.13 points or 4.09% above its previous close of $3.18. vTv Therapeutics Inc. (VTVT) < is currently trading at $3.21 + 0.03 (0.94%).

vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer\’s and type-II diabetes. Its other products include TTP399, type II diabetes drug candidate.

Scorpio Bulkers Inc. (SALT) < (SALT) had a gap up today of 0.125 points or 3.32% above its previous close of $3.76. Scorpio Bulkers Inc. (SALT) < is currently trading at $4.02 + 0.26 (6.91%).

Scorpio Bulkers Inc is a shipping company. Its core activity is marine transportation of goods such as include iron ore, coal and grain and minor bulks which include bauxite, fertilizers and steel products.

Allena Pharmaceuticals Inc. (ALNA) < (ALNA) had a gap up today of 0.16 points or 6.48% above its previous close of $2.47. Allena Pharmaceuticals Inc. (ALNA) < is currently trading at $2.60 + 0.13 (5.26%).

Allena Pharmaceuticals Inc is a clinical biopharmaceutical company. It focuses on developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders.

ADMA Biologics Inc (ADMA) < (ADMA) had a gap up today of 0.16 points or 4.46% above its previous close of $3.59. ADMA Biologics Inc (ADMA) < is currently trading at $3.61 + 0.025 (0.70%).

ADMA Biologics Inc is a biopharmaceutical company. The company develops and manufactures specialty plasma-based biologics for the proposed treatment of immune deficiencies and prevention of certain infectious diseases.

Datasea Inc. (DTSS) < (DTSS) had a gap up today of 0.69 points or 26.34% above its previous close of $2.62. Datasea Inc. (DTSS) < is currently trading at $3.18 + 0.56 (21.37%).

Datasea Inc.is a development stage company engaged in the Internet security products in China.

Gaps Down

Kala Pharmaceuticals Inc. (KALA) < (KALA) had a gap down today of (0.79) points or -12.34% below its previous close of $6.40. Kala Pharmaceuticals Inc. (KALA) < is currently trading at $6.30 - 0.0902 (1.41%).

Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.

Telenav Inc. (TNAV) < (TNAV) had a gap down today of (1.11) points or -17.90% below its previous close of $6.20. Telenav Inc. (TNAV) < is currently trading at $5.44 - 0.76 (12.26%).

Telenav Inc is a provider of connected car and location-based platform services. Its services consist of map and navigation platform and advertising delivery platform.

Rexahn Pharmaceuticals Inc. (REXN) < (REXN) had a gap down today of (1.14) points or -31.15% below its previous close of $3.66. Rexahn Pharmaceuticals Inc. (REXN) < is currently trading at $3.07 - 0.59 (16.12%).

Rexahn Pharmaceuticals Inc is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of treatments for cancer.

Xeris Pharmaceuticals Inc. (XERS) < (XERS) had a gap down today of (1.46) points or -33.72% below its previous close of $4.33. Xeris Pharmaceuticals Inc. (XERS) < is currently trading at $4.06 - 0.27 (6.24%).

Xeris Pharmaceuticals Inc is a specialty pharmaceutical company leveraging its novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations.

Alex Fredricks

Alex Fredricks

Alex Fredricks has a degree in business and is an avid day-trader. Alex's experience and love for the game of the markets is shown not only in his posts, but the post he helps edit for other authors on our staff.